Ro 61–1790, a New Hydrosoluble Endothelin Antagonist: General Pharmacology and Effects on Experimental Cerebral Vasospasm

Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides

Michael J. Berridge, R. M. C. Dawson, C. Peter Downes et al. · Biochemical Journal · 1983 · 2K citations · Full text

Life Sciences, Biochemistry, Entomology +14

Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.

Martine Clozel, Volker Breu, Gillian A. Gray et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 668 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure

Wolfgang Kiowski, J Kim, Erwin Oechslin et al. · The Lancet · 1995 · 573 citations

Life Sciences, Cardiology, Physiology +11

Treatment of cerebral vasospasm with intra-arterial papaverine

Neal F. Kassell, Gregory A. Helm, Nathan E. Simmons et al. · Journal of neurosurgery · 1992 · 380 citations

Medicine, Neurology, Pharmacotherapy +15

A New Method for Continuous Chronic Measurement and Recording of Blood Pressure, Heart Rate and Activity in the Rat Via Radio-telemetry

Brian Brockway, Perry Mills, Silvia H. Azar · Clinical and Experimental Hypertension Part A Theory and Practice · 1991 · 249 citations

Engineering, Bioengineering, Physiology +17